Talaris Therapeutics Inc TALS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11/23/22 EST
1.47UNCH (UNCH)
Volume
77,292
52 week range
1.16 - 16.63
Loading...
  • Open1.43
  • Day High1.47
  • Day Low1.40
  • Prev Close1.47
  • 52 Week High16.63
  • 52 Week High Date01/03/22
  • 52 Week Low1.16
  • 52 Week Low Date10/20/22

Key Stats

  • Market Cap61.332M
  • Shares Out41.72M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-90.39

KEY STATS

  • Open1.43
  • Day High1.47
  • Day Low1.40
  • Prev Close1.47
  • 52 Week High16.63
  • 52 Week High Date01/03/22
  • 52 Week Low1.16
  • 52 Week Low Date10/20/22
  • Market Cap61.332M
  • Shares Out41.72M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-90.39

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-0.87
  • Fwd P/E (NTM)-0.72
  • EBITDA (TTM)-69.54M
  • ROE (TTM)-30.90%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/17/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Talaris Therapeutics Inc

 

Profile

MORE
Talaris Therapeutics, Inc. is a late-clinical stage, cell therapy company developing therapies. The Company is principally focused on developing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The Company's lead product candidate, FCR001, which is central to its facilitated Allo-HSCT therapy, is an allogeneic cell therapy comprised of stem and immune cells that are procured from a healthy donor. FCR001 is processed in the Company's good manufacturing practice...
Francois Nader M.D.
Independent Chairman of the Board
Scott Requadt J.D.
President, Chief Executive Officer, Director
Mary Fenton CPA
Chief Financial Officer, Treasurer
Michael Zdanowski
Chief Technology Officer
Address
570 Preston St., Suite 400
Louisville, KY
40202
United States

Top Peers

SYMBOLLASTCHG%CHG
RVPH
Reviva Pharmaceuticals Holdings, Inc.
3.98UNCHUNCH
GNPX
Genprex Inc
1.29UNCHUNCH
BCLI
Brainstorm Cell Therapeutics Inc
1.70UNCHUNCH
CKPT
Checkpoint Therapeutics Inc
0.65UNCHUNCH
LIFE
aTyr Pharma Inc
2.15UNCHUNCH